Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.290
-0.100 (-2.95%)
Feb 21, 2025, 4:00 PM EST - Market closed
Grace Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 33 | 32 | 21 | 54 | 120 | 34 | |
| Market Cap Growth | 39.61% | 56.91% | -62.03% | -55.00% | 250.73% | -57.04% | |
| Enterprise Value | 22 | 7 | -10 | 8 | 92 | 16 | |
| Last Close Price | 3.29 | 3.42 | 2.76 | 7.32 | 28.80 | 18.22 | |
| Debt / Equity Ratio | - | - | 0.01 | 0.00 | 0.00 | 0.01 | |
| Asset Turnover | - | - | - | - | 0.00 | - | |
| Quick Ratio | 5.76 | 14.09 | 8.41 | 13.56 | 38.80 | 2.00 | |
| Current Ratio | 6.06 | 14.26 | 8.59 | 13.89 | 39.50 | 2.50 | |
| Return on Equity (ROE) | -22.89% | -19.82% | -48.15% | -11.98% | -57.33% | -212.26% | |
| Return on Assets (ROA) | -15.16% | -9.25% | -10.96% | -7.94% | -15.70% | -51.13% | |
| Return on Capital (ROIC) | -17.83% | -10.83% | -12.86% | -9.24% | -19.44% | -119.57% | |
| Buyback Yield / Dilution | -34.86% | -28.16% | -21.09% | -148.46% | -40.25% | -55.80% | |
| Total Shareholder Return | -34.86% | -28.16% | -21.09% | -148.46% | -40.25% | -55.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.